1-6 of 6
Keith D. Kaufman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

Abhinav Sharma, Yinggan Zheng, Justin A. Ezekowitz, Cynthia M. Westerhout, Jacob A. Udell, Shaun G. Goodman, Paul W. Armstrong, John B. Buse, Jennifer B. Green, Robert G. Josse, Keith D. Kaufman, Darren K. McGuire, Giuseppe Ambrosio, Lee-Ming Chuang, Renato D. Lopes, Eric D. Peterson, Rury R. Holman
Journal: Diabetes Care
Diabetes Care 2022;45(1):204–212
https://doi.org/10.2337/dc20-2806
Published: 29 October 2021
View article titled, Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine
Open the PDF for Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine in another window
Journal Articles

Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial

Abhinav Sharma, Jennifer B. Green, Allison Dunning, Yuliya Lokhnygina, Sana M. Al-Khatib, Renato D. Lopes, John B. Buse, John M. Lachin, Frans Van de Werf, Paul W. Armstrong, Keith D. Kaufman, Eberhard Standl, Juliana C.N. Chan, Larry A. Distiller, Russell Scott, Eric D. Peterson, Rury R. Holman
Journal: Diabetes Care
Diabetes Care 2017;40(12):1763–1770
https://doi.org/10.2337/dc17-1091
Published: 06 October 2017
View article titled, Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial
Open the PDF for Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial in another window
Includes: Supplementary data
Journal Articles

Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

M. Angelyn Bethel, Samuel S. Engel, Jennifer B. Green, Zhen Huang, Robert G. Josse, Keith D. Kaufman, Eberhard Standl, Shailaja Suryawanshi, Frans Van de Werf, Darren K. McGuire, Eric D. Peterson, Rury R. Holman
Journal: Diabetes Care
Diabetes Care 2017;40(4):494–501
https://doi.org/10.2337/dc16-1135
Published: 05 January 2017
View article titled, Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
Open the PDF for Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in another window
Includes: Supplementary data
Journal Articles

Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes

Wayne H.-H. Sheu, Ira Gantz, Menghui Chen, Shailaja Suryawanshi, Arpana Mirza, Barry J. Goldstein, Keith D. Kaufman, Samuel S. Engel
Journal: Diabetes Care
Diabetes Care 2015;38(11):2106–2114
https://doi.org/10.2337/dc15-0109
Published: 26 August 2015
View article titled, Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes
Open the PDF for Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency

Juan Camilo Arjona Ferreira, MD, Michel Marre, MD, Nir Barzilai, MD, Hua Guo, PHD, Gregory T. Golm, PHD, Christine McCrary Sisk, BS, Keith D. Kaufman, MD, Barry J. Goldstein, MD
Journal: Diabetes Care
Diabetes Care 2013;36(5):1067–1073
https://doi.org/10.2337/dc12-1365
Published: 13 April 2013
View article titled, Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency
Open the PDF for Efficacy and Safety of Sitagliptin Versus Glipizide in Patients With Type 2 Diabetes and Moderate-to-Severe Chronic Renal Insufficiency in another window
Includes: Supplementary data
Journal Articles

Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes

Gary E. Meininger, MD, Russell Scott, MD, Maria Alba, MD, Yue Shentu, PHD, Edmund Luo, PHD, Himal Amin, BS, Michael J. Davies, PHD, Keith D. Kaufman, MD, Barry J. Goldstein, MD
Journal: Diabetes Care
Diabetes Care 2011;34(12):2560–2566
https://doi.org/10.2337/dc11-1200
Published: 14 November 2011
View article titled, Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
Open the PDF for Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes in another window
Includes: Supplementary data